Pharmakon Health And Beauty Care Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 19-12-2024
- Paid Up Capital ₹ 0.10 M
as on 19-12-2024
- Company Age 10 Year, 25 Days
- Last Filing with ROC 31 Mar 2024
- Revenue 216.91%
(FY 2021)
- Profit 147.47%
(FY 2021)
- Ebitda 1225.23%
(FY 2021)
- Net Worth 16.84%
(FY 2021)
- Total Assets 2.74%
(FY 2021)
About Pharmakon Health And Beauty Care
The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Kuldip Sharma and Kulbhushan Sharma serve as directors at the Company.
- CIN/LLPIN
U74999DL2014PTC274463
- Company No.
274463
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Dec 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Pharmakon Health And Beauty Care Private Limited offer?
Pharmakon Health And Beauty Care Private Limited offers a wide range of products and services, including Cosmetics, Hair & Beauty Products, Skin Care Cosmetics, Beauty Cosmetics, Cosmetic Third Party Manufacturing, Hair Care Products, Hand Sanitizers & Personal Hygiene, Face Wash, Hand Wash, Skin Care Third Party Manufacturing, Carrier Oil.
Who are the key members and board of directors at Pharmakon Health And Beauty Care?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kulbhushan Sharma  | Director | 22-Dec-2014 | Current |
| Kuldip Sharma | Director | 22-Dec-2014 | Current |
Financial Performance of Pharmakon Health And Beauty Care.
Pharmakon Health And Beauty Care Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 216.91% increase. The company also saw a substantial improvement in profitability, with a 147.47% increase in profit. The company's net worth Soared by an impressive increase of 16.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pharmakon Health And Beauty Care?
In 2021, Pharmakon Health And Beauty Care had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pharmakon Health And Beauty Care?
Unlock and access historical data on people associated with Pharmakon Health And Beauty Care, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pharmakon Health And Beauty Care, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharmakon Health And Beauty Care's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
